| Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial BP Halliday, R Wassall, AS Lota, Z Khalique, J Gregson, S Newsome, ... The Lancet 393 (10166), 61-73, 2019 | 554 | 2019 |
| Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma MR Bishop, M Dickinson, D Purtill, P Barba, A Santoro, N Hamad, K Kato, ... New England Journal of Medicine 386 (7), 629-639, 2022 | 357 | 2022 |
| Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction BP Halliday, A Gulati, A Ali, K Guha, S Newsome, M Arzanauskaite, ... Circulation 135 (22), 2106-2115, 2017 | 330 | 2017 |
| Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement BP Halliday, AJ Baksi, A Gulati, A Ali, S Newsome, C Izgi, ... JACC: Cardiovascular Imaging 12 (8 Part 2), 1645-1655, 2019 | 233 | 2019 |
| Sex‐and age‐based differences in the natural history and outcome of dilated cardiomyopathy BP Halliday, A Gulati, A Ali, S Newsome, A Lota, U Tayal, VS Vassiliou, ... European journal of heart failure 20 (10), 1392-1400, 2018 | 122 | 2018 |
| Phenotype and clinical outcomes of titin cardiomyopathy U Tayal, S Newsome, R Buchan, N Whiffin, B Halliday, A Lota, A Roberts, ... Journal of the American College of Cardiology 70 (18), 2264-2274, 2017 | 102 | 2017 |
| Data resource profile: the UK cystic fibrosis registry D Taylor-Robinson, O Archangelidi, SB Carr, R Cosgriff, E Gunn, ... International journal of epidemiology 47 (1), 9-10e, 2018 | 85 | 2018 |
| Truncating variants in titin independently predict early arrhythmias in patients with dilated cardiomyopathy U Tayal, S Newsome, R Buchan, N Whiffin, R Walsh, PJ Barton, JS Ware, ... Journal of the American College of Cardiology 69 (19), 2466-2468, 2017 | 66 | 2017 |
| Microvascular dysfunction in dilated cardiomyopathy: a quantitative stress perfusion cardiovascular magnetic resonance study A Gulati, TF Ismail, A Ali, LY Hsu, C Gonçalves, NA Ismail, ... JACC: Cardiovascular Imaging 12 (8 Part 2), 1699-1708, 2019 | 59 | 2019 |
| Absence of myocardial fibrosis predicts favorable long-term survival in new-onset heart failure: a cardiovascular magnetic resonance study A Gulati, AG Japp, S Raza, BP Halliday, DA Jones, S Newsome, ... Circulation: Cardiovascular Imaging 11 (9), e007722, 2018 | 55 | 2018 |
| Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score SJ Pocock, Y Huo, F Van de Werf, S Newsome, CT Chin, AM Vega, ... European Heart Journal: Acute Cardiovascular Care 8 (8), 727-737, 2019 | 46 | 2019 |
| External aortic root support to prevent aortic dilatation in patients with Marfan syndrome C Izgi, S Newsome, F Alpendurada, E Nyktari, M Boutsikou, J Pepper, ... Journal of the American College of Cardiology 72 (10), 1095-1105, 2018 | 46 | 2018 |
| Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry U Zeymer, L Annemans, N Danchin, S Pocock, S Newsome, ... European Heart Journal: Acute Cardiovascular Care 8 (2), 121-129, 2019 | 45 | 2019 |
| Predictors of left ventricular remodelling in patients with dilated cardiomyopathy–a cardiovascular magnetic resonance study U Tayal, R Wage, S Newsome, R Manivarmane, C Izgi, A Muthumala, ... European journal of heart failure 22 (7), 1160-1170, 2020 | 35 | 2020 |
| Estimating long‐term treatment effects in observational data: A comparison of the performance of different methods under real‐world uncertainty S Newsome, R Keogh, R Daniel Statistics in Medicine, 2018 | 34 | 2018 |
| Precision phenotyping of dilated cardiomyopathy using multidimensional data U Tayal, JAJ Verdonschot, MR Hazebroek, J Howard, J Gregson, ... Journal of the American College of Cardiology 79 (22), 2219-2232, 2022 | 30 | 2022 |
| Tisagenlecleucel vs standard of care as second-line therapy of primary refractory or relapsed aggressive B-cell non-Hodgkin lymphoma: analysis of the phase III Belinda study MR Bishop, M Dickinson, D Purtill, P Barba, A Santoro, N Hamad, K Kato, ... Blood 138, LBA-6, 2021 | 23 | 2021 |
| Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation CE Raphael, F Mitchell, GS Kanaganayagam, AC Liew, E Di Pietro, ... Journal of Cardiovascular Magnetic Resonance 23 (1), 26, 2021 | 20 | 2021 |
| Investigating the effects of long-term dornase alfa use on lung function using registry data SJ Newsome, RM Daniel, SB Carr, D Bilton, RH Keogh Journal of cystic fibrosis 18 (1), 110-117, 2019 | 19 | 2019 |
| Lipoprotein (a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance VS Vassiliou, PD Flynn, CE Raphael, S Newsome, T Khan, A Ali, ... PLoS One 12 (7), e0181077, 2017 | 18 | 2017 |
